The ones that are worried that rising bond yields caused by inflation will make capital more expensive for cash burning techc os and biotechs and will also discount the value of future cash flows. Did you not notice the 10% Nasdaq correction a couple of weeks back? Many think it has much further to fall if bond yields keep rising
No but I think investors in the US are extremely worried that many biotechs like Seres are wildly overvalued so it is not a great time to get the message across especially being British and all that.
You need more than BOD PR Nelson. The Tils guys are on Bloomberg TV every other week and fat lot of good it does. You need catalysts otherwise how do you expect to stand out for the other 700 biotechs on Nasdaq?
Readouts from the MRx0518/Keytruda should be ever 3-4 months as initial data comes in. Preliminary data on Pancreatic cancer P1 and asthma and covid P2 for later in the year. News due later in the year on vaccine collaboration with MSD
Right now today with so much still to be done £2.5bn would be realistic. It would be a share price of about £12-15. I would take that today but I would want much more if we continue to make significant progress.